Results 31 to 40 of about 32,907 (227)

Daptomycin‐induced hyperkalemia: A case report and brief description of mechanism

open access: yesClinical Case Reports, 2023
Key Clinical Message Daptomycin causes serious side effects like rhabdomyolysis at high doses. At lower doses it can cause isolated hyperkalemia without frank rhabdomyolysis.
Praveen Errabelli   +2 more
doaj   +1 more source

Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men [PDF]

open access: yes, 2023
Hyperkalemia is common among patients with chronic kidney disease (CKD) but there is scarce information on differential risk factors and outcomes for men and women.
Fernández Fernández, Beatriz   +5 more
core   +1 more source

Management of Hyperkalemia in Heart Failure

open access: yes, 2021
Hyperkalemia is a common electrolyte abnormality in heart failure (HF) that can cause potentially life-threatening cardiac arrhythmias and sudden cardiac death.
Celik, Ahmet   +6 more
core   +2 more sources

Predictors for repeated hyperkalemia and potassium trajectories in high-risk patients - A population-based cohort study.

open access: yesPLoS ONE, 2019
Understanding predictors and trajectories of increased potassium may inform testing and treatment of hyperkalemia. We examined predictors for repeated hyperkalemia among patients after first-time renin angiotensin system inhibitor (RASi) prescription ...
Kasper Adelborg   +5 more
doaj   +1 more source

Recurrent Hyperkalemia During General Anesthesia in a Dog

open access: yesFrontiers in Veterinary Science, 2020
Objective: To describe the development of recurrent hyperkalemia in a dog that underwent general anesthesia at two different hospitals within a month. The definitive underlying cause of the hyperkalemia remains unknown.Case summary: A 11 year-old male ...
Carissa W. Tong   +2 more
doaj   +1 more source

Hyperkalemia and Renin-Angiotensin-Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction. [PDF]

open access: yes, 2019
Renin-angiotensin-aldosterone system inhibitors (RAASi) are known to improve outcomes in patients who have heart failure with reduced ejection fraction (HFrEF).
Agewall, S,   +12 more
core   +1 more source

Serum potassium levels of patients on angiotensin converting enzyme inhibitors – A cross-sectional study

open access: yesNational Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Angiotensin-converting enzyme (ACE) inhibitors are commonly used in clinical practice to treat hypertension. Hyperkalemia develops in approximately 10% of outpatients within a year of prescription of these drugs.
Vishnupriya Ramakrishnan   +1 more
doaj   +1 more source

ECG alterations suggestive of hyperkalemia in normokalemic versus hyperkalemic patients

open access: yesBMC Emergency Medicine, 2019
Background In periarrest situations and during resuscitation it is essential to rule out reversible causes. Hyperkalemia is one of the most common, reversible causes of periarrest situations.
Csaba Varga   +9 more
doaj   +1 more source

Hyperkalemia in chronic peritoneal dialysis patients

open access: yesRenal Failure, 2022
Background. Chronic peritoneal dialysis (PD) patients often develop hypokalemia but less commonly hyperkalemia. Methods. We explored incidence and mechanisms of hyperkalemia in 779 serum samples from 33 patients on PD for 1 − 59 months.
Andrew B. Elliott   +2 more
doaj   +1 more source

Hyperkalemia-induced brugada phenocopy: A rare electrocardiogram manifestation

open access: yesJournal of the Practice of Cardiovascular Sciences, 2022
Hyperkalemia-induced Brugada ECG pattern is rare. Although the association of hyperkalemia with Brugada pattern is a known entity, it is also very important to be aware of this presentation as the treatment of this Brugada Phenocopy is different from ...
Satyajit Singh   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy